Inveltys Side Effects Center

Last updated on RxList: 8/22/2022
Inveltys Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

What Is Inveltys?

Inveltys (loteprednol etabonate ophthalmic suspension) is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular surgery.

What Are Side Effects of Inveltys?

Common side effects of Inveltys include:

These reactions may be a consequence of the surgical procedure.

Inveltys may cause serious side effects including:

  • hives, 
  • difficulty breathing, 
  • swelling of your face, lips, tongue, or throat, 
  • vision changes, 
  • decreased vision, and
  • eye pain 

Get medical help right away, if you have any of the symptoms listed above.

Seek medical care or call 911 at once if you have the following serious side effects:

  • Serious eye symptoms such as sudden vision loss, blurred vision, tunnel vision, eye pain or swelling, or seeing halos around lights;
  • Serious heart symptoms such as fast, irregular, or pounding heartbeats; fluttering in your chest; shortness of breath; and sudden dizziness, lightheartedness, or passing out;
  • Severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff muscles, high fever, profuse sweating, or tremors.

This document does not contain all possible side effects and others may occur. Check with your physician for additional information about side effects.

Dosage for Inveltys

The dose of Inveltys is one to two drops of instilled into the affected eye twice daily beginning the day after surgery and continuing throughout the first 2 weeks of the post-operative period.

What Drugs, Substances, or Supplements Interact with Inveltys?

Inveltys may interact with other drugs. Tell your doctor all medications and supplements you use.

Inveltys During Pregnancy and Breastfeeding

Tell your doctor if you are pregnant or plan to become pregnant before using Inveltys. Inveltys is not absorbed systemically following topical ophthalmic administration and maternal use is not expected to result in fetal exposure to the drug. Inveltys is not absorbed systemically by the mother following topical ophthalmic administration, and breastfeeding is not expected to result in exposure of the child to Inveltys. Consult your doctor before breastfeeding.

Additional Information

Our Inveltys (loteprednol etabonate ophthalmic suspension) 1%, for Topical Ophthalmic Use Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


Pink Eye (Conjunctivitis) Symptoms, Causes, Treatments See Slideshow
Inveltys Consumer Information

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • pain when using the eye drops;
  • worsening redness or itching;
  • eye pain or swelling, trouble closing your eye;
  • pain behind your eyes, sudden vision changes;
  • tunnel vision, seeing halos around lights; or
  • signs of eye infection--redness, severe discomfort, crusting or drainage.

Common side effects may include:

  • minor burning when using the eye drops;
  • eye pain, blurred vision;
  • dry or watery eyes;
  • feeling like something is in your eye;
  • your eyes may be more sensitive to light;
  • headache; or
  • runny nose, sore throat.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Inveltys (Loteprednol Etabonate Suspension)


What causes dry eyes? See Answer
Inveltys Professional Information


Adverse reactions associated with ophthalmic steroids include elevated intraocular pressure, which may be associated with infrequent optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, delayed wound healing and secondary ocular infection from pathogens including herpes simplex, and perforation of the globe where there is thinning of the cornea or sclera.

Clinical Trial Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

The most common adverse drug reactions in the clinical trials with INVELTYS were eye pain and posterior capsular opacification, both reported in 1% of patients. These reactions may have been the consequence of the surgical procedure.

Read the entire FDA prescribing information for Inveltys (Loteprednol Etabonate Suspension)

© Inveltys Patient Information is supplied by Cerner Multum, Inc. and Inveltys Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors